Dupont Capital Management Corp Cytokinetics Inc Transaction History

Dupont Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$15.26 - $28.61 $227,709 - $426,918	-14,922 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$20.58 - $28.96 $20,580 - $28,960	-1,000 Reduced 6.28%	14,922 $323,000
Q2 2020 Jul 24, 2020	SELL	$11.15 - $24.64 $77,983 - $172,332	-6,994 Reduced 30.52%	15,922 $375,000
Q1 2020 Apr 29, 2020	BUY	$8.75 - $16.3 $200,515 - $373,530	22,916 New	22,916 $270,000
Q4 2017 Jan 31, 2018	SELL	$7.25 - $15.65 $166,315 - $359,011	-22,940 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$12.0 - $15.0 $275,280 - $344,100	22,940	22,940 $333,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.76B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.